文献速递呼吸衰竭与机械通气儿科与产科急症

新生儿气管插管时经鼻高流量治疗

Nasal High-Flow Therapy during Neonatal Endotracheal Intubation.
PubMed 文献 · N Engl J Med · 2022-01-01
一句话结论在澳大利亚两个三级新生儿ICU中,新生儿气管插管时使用经鼻高流量治疗可提高首次尝试且无生理不稳定的插管成功率(50.0% vs 31.5%)。

该随机对照试验在澳大利亚两个三级新生儿ICU进行,比较经鼻高流量治疗与标准治疗(无经鼻高流量或补充氧)在新生儿经口气管插管中的效果。主要结局为首次插管成功且无生理不稳定(外周血氧饱和度较插管前基线绝对下降>20%或心率<100次/分的心动过缓)。意向性治疗分析纳入202名婴儿的251次插管,高流量组124次中62次(50.0%)达到主要结局,标准治疗组127次中40次(31.5%)达到,校正风险差17.6个百分点(95%CI 6.0至29.2),需治疗人数为6(95%CI 4至17)。结论认为经鼻高流量治疗提高了首次插管成功且无生理不稳定的可能性。

要点

  • 在202名新生儿(中位矫正胎龄27.9周,中位体重920 g)的251次插管中,高流量组50.0%(62/124)首次插管成功且无生理不稳定,标准治疗组31.5%(40/127),校正风险差17.6个百分点(95%CI 6.0至29.2)。
  • 每治疗6名婴儿(95%CI 4至17)即有1名受益于经鼻高流量治疗,主要结局为首次插管成功且无生理不稳定。
  • 不考虑生理稳定性时,高流量组首次插管成功率为68.5%,标准治疗组为54.3%,校正风险差15.8个百分点(95%CI 4.3至27.3)。
  • 生理不稳定定义为外周血氧饱和度较插管前基线绝对下降>20%或心率<100次/分的心动过缓。
  • 研究在澳大利亚两个三级新生儿ICU进行,随机化按试验中心、插管前用药(是或否)及矫正胎龄(≤28或>28周)分层。

适用人群与场景

  • 在澳大利亚两个三级新生儿ICU接受经口气管插管的新生儿;中位矫正胎龄27.9周,中位体重920 g。
  • 随机化按试验中心、插管前用药(是或否)及矫正胎龄(≤28或>28周)分层。

诊断标准与关键阈值

  • 生理不稳定定义:外周血氧饱和度较插管前基线水平绝对下降>20%,或心率<100次/分的心动过缓。
  • 主要结局:首次尝试插管成功且无生理不稳定。

处置流程与药物剂量

  • 干预组在插管过程中接受经鼻高流量治疗;对照组接受标准治疗(无经鼻高流量治疗或补充氧)。

红旗征与不能漏的情况

  • 插管过程中出现外周血氧饱和度较插管前基线绝对下降>20%或心率<100次/分的心动过缓,即视为生理不稳定。

研究设计与关键结果

  • 研究类型:随机对照试验;在两个澳大利亚三级新生儿ICU进行;意向性治疗分析纳入202名婴儿的251次插管(高流量组124次,标准治疗组127次)。
  • 主要结局:首次插管成功且无生理不稳定在高流量组为50.0%(62/124),标准治疗组为31.5%(40/127),校正风险差17.6个百分点(95%CI 6.0至29.2),需治疗人数6(95%CI 4至17)。
  • 不考虑生理稳定性的首次插管成功率:高流量组68.5%,标准治疗组54.3%,校正风险差15.8个百分点(95%CI 4.3至27.3)。
  • 研究由National Health and Medical Research Council资助;澳大利亚新西兰临床试验注册号ACTRN12618001498280。

证据类型、等级与局限

  • 证据类型:随机对照试验。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 在澳大利亚两个三级新生儿ICU接受气管插管的新生儿中,插管过程中使用经鼻高流量治疗可能提高首次插管成功且无生理不稳定的可能性。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Neonatal endotracheal intubation often involves more than one attempt, and oxygen desaturation is common. It is unclear whether nasal high-flow therapy, which extends the time to desaturation during elective intubation in children and adults receiving general anesthesia, can improve the likelihood of successful neonatal intubation on the first attempt.

METHODS: We performed a randomized, controlled trial to compare nasal high-flow therapy with standard care (no nasal high-flow therapy or supplemental oxygen) in neonates undergoing oral endotracheal intubation at two Australian tertiary neonatal intensive care units. Randomization of intubations to the high-flow group or the standard-care group was stratified according to trial center, the use of premedication for intubation (yes or no), and postmenstrual age of the infant (≤28 or >28 weeks). The primary outcome was successful intubation on the first attempt without physiological instability (defined as an absolute decrease in the peripheral oxygen saturation of >20% from the preintubation baseline level or bradycardia with a heart rate of <100 beats per minute) in the infant.

RESULTS: The primary intention-to-treat analysis included the outcomes of 251 intubations in 202 infants; 124 intubations were assigned to the high-flow group and 127 to the standard-care group. The infants had a median postmenstrual age of 27.9 weeks and a median weight of 920 g at the time of intubation. A successful intubation on the first attempt without physiological instability was achieved in 62 of 124 intubations (50.0%) in the high-flow group and in 40 of 127 intubations (31.5%) in the standard-care group (adjusted risk difference, 17.6 percentage points; 95% confidence interval [CI], 6.0 to 29.2), for a number needed to treat of 6 (95% CI, 4 to 17) for 1 infant to benefit. Successful intubation on the first attempt regardless of physiological stability was accomplished in 68.5% of the intubations in the high-flow group and in 54.3% of the intubations in the standard-care group (adjusted risk difference, 15.8 percentage points; 95% CI, 4.3 to 27.3).

CONCLUSIONS: Among infants undergoing endotracheal intubation at two Australian tertiary neonatal intensive care units, nasal high-flow therapy during the procedure improved the likelihood of successful intubation on the first attempt without physiological instability in the infant. (Funded by the National Health and Medical Research Council; Australian New Zealand Clinical Trials Registry number, ACTRN12618001498280.).

来源:N Engl J Med,查看原文。版权归原作者所有。

参考来源

  1. Hodgson KA, Owen LS, Kamlin COF, et al. Nasal High-Flow Therapy during Neonatal Endotracheal Intubation. N Engl J Med. 2022. PMID: 35476651. doi:10.1056/NEJMoa2116735

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。